Pamela Klein
Hematology & Oncology · San Francisco, CANPI 1851254171
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $398,721 of the $509,601 with a category attached, or 78.2%. Every reported general payment came from a single manufacturer, Argenx US, Inc.. Among hematology & oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $8493.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Argenx US, Inc.$510K
What the payments were for
- Consulting fees$398,72178%
- Speaking & faculty fees$82,98216%
- Travel & lodging$25,5775%
- Food & beverage$2,3220%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Argenx US, Inc. | 60 | $509,601 |
How this compares
$509,601 in reported general payments places this provider in the 95th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in San Francisco
- Aaron LoganSan Francisco$333K
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.